|Bid||1.2000 x 1300|
|Ask||1.3300 x 800|
|Day's Range||1.2800 - 1.3300|
|52 Week Range||1.0710 - 5.3500|
|Beta (3Y Monthly)||2.32|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Montreal-based company said it had a loss of 38 cents per share. Earnings, adjusted for non-recurring costs, were 19 cents per share. The beverage company posted revenue of $62.5 million in the period. ...
Many marijuana stocks tumble amid continued uncertainty over the legality of their products in the United States.
DAVIDSTea added that for the same quarter, its net loss came in at $7.4 million on an adjusted, or approximately 28 cents per share. In the third quarter of its fiscal 2017, the company added that it brought in a net loss of $4.5 million, or 17 cents per share. DAVIDSTea’s revenue did increase 1.5% compared to the tea accessory seller’s year-ago quarter to $43.7 million from its previous total of roughly $43 million.
Wall Street is expecting good things from DAVIDsTEA's earnings after the closing bell, sending the stock soaring.
Cannabis stocks were struggling mostly to keep up with the rest of the market's gains Monday, Dec. 3, but a couple of pot stocks were trading in the green. was climbing more than 9% Monday after the soft drinks maker said it was acquiring Morinda Holdings, a cannabis-infused drink seller, for $85 million. "This acquisition has potential to expand their strategic push into cannabis infused beverages globally, and further strengthens their award-winning healthy beverage portfolio," a spokeswoman for New Age Beverages said in an email to TheStreet.
Fellow pot stocks that had strong days of trading Wednesday like Tilray Inc. Canopy Growth shares declined 2.5% to $33.15, while DAVIDsTEA fell 4.17% to $2.07, Aurora Cannabis fell 5.2% to $5.65 and Tilray fell 3.3% to $107.20.
Cannabis is officially legal in Canada Wednesday, but stocks in the segment are falling across the board.
The jump came after short-seller Andrew Left's Citron Research published a bullish note on the company. $PYX would not short...speculative long. Learn more about TheStreet's market coverage for your trusted smart-speaker here.
Count Citron Research is a believer in tobacco and cannabis company Pyxus International Inc. , following a bullish research note on the company Monday, October 8. Citron believes that the North Carolina-based company could double from its opening position Monday, as long as investors are still pot crazy.